[Therapeutic use of a nicofuranosio-centrophenoxine association in involutive psychoses].
D000368:Aged; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003704:Dementia / Q000188:drug therapy*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D002504:Meclofenoxate / Q000627:therapeutic use; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000697:Central Nervous System Stimulants; D014665:Vasodilator Agents; D002504:Meclofenoxate
L'impiego terapeutico dell'associazione nicofuranosio-centrofenoxina nelle psicosi involutive.